[1]
2025. Analysis of depression in Brazil and the feasibility of incorporating pharmacogenomics as an auxiliary tool in antidepressant treatment. Brazilian Journal of Pharmaceutical Sciences. 61, (Feb. 2025). DOI:https://doi.org/10.1590/.